南網儲能(600995.SH):佛山南海電化學儲能項目計劃今年底前投產
格隆匯9月5日丨南網儲能(600995.SH)接受特定對象調研時表示,公司目前在建抽蓄4座,裝機容量480萬千瓦,力爭2025年底前投產360萬千瓦。同時,公司圍繞十五五投產目標,正在抓緊開展一批抽水蓄能電站前期工作,將在項目取得核准後開工建設。
佛山南海電化學儲能項目裝機容量30萬千瓦/60萬千萬時,計劃今年底前投產。公司新型儲能項目儲備達到700萬千瓦以上,目前政策和市場環境均持續向好,公司緊密跟蹤政策出台情況,一旦具有可行的投資回報模式,就將加快推進項目落地建設,規劃2023-2025年均有項目建成投產,具體到每年的投產進度,還要看相關政策的落地情況。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.